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OBJECTIVES The aim of this study was to determine the effect of exercise training on myocardial oxidative
metabolism and efficiency in patients with idiopathic dilated cardiomyopathy (DCM) and
mild heart failure (HF).
BACKGROUND Exercise training is known to improve exercise tolerance and quality of life in patients with
chronic HF. However, little is known about how exercise training may influence myocardial
energetics.
METHODS Twenty clinically stable patients with DCM (New York Heart Association classes I through
III) were prospectively separated into a training group (five-month training program; n  9)
and a non-trained control group (n  11). Oxidative metabolism in both the right and left
ventricles (RV and LV) was measured using [11C]acetate and positron emission tomography.
Myocardial work power was measured using echocardiography. Myocardial efficiency for
forward work was calculated as myocardial work power per mass/LV oxidative metabolism.
RESULTS Significant improvements were noted in exercise capacity (VO2) and ejection fraction in the
training group, whereas no changes were observed in the non-trained group. Exercise training
reduced both RV and LV oxidative metabolism and elicited a significant increase in LV
forward work efficiency, although no significant changes were observed in the non-trained
group.
CONCLUSIONS Exercise training improves exercise tolerance and LV function. This is accompanied by a
decrease in biventricular oxidative metabolism and enhanced forward work efficiency.
Therefore, exercise training elicits an energetically favorable improvement in myocardial
function and exercise tolerance in patients with DCM. (J Am Coll Cardiol 2003;41:460–7)
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Heart failure (HF) is a growing health problem in indus-
trialized countries that will continue to worsen as the aged
population increases. In HF patients, exercise training
programs have proven to be safe and effective at improving
many functional parameters such as exercise capacity (1–3),
muscular strength (2,4,5), and health-related quality of life
(1). The training benefits achieved in patients with HF have
been primarily associated with peripheral vasculature adap-
tations, including improvements in peripheral endothelial
function (6), increased proportion of type 1 skeletal muscle
fibers (7), and enhanced skeletal muscle oxidative capacity
(5,7). Studies have also investigated possible central changes
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with exercise training but have primarily focused on the
functional parameters of the heart itself (3,8). The effect of
exercise training on myocardial oxidative metabolism has
not been previously investigated.
The use of positron emission tomography (PET) and
[11C]acetate is unique as it allows assessment of flux
through the tricarboxylic acid cycle and thus provides an
estimation of myocardial oxidative metabolism in both the
right and left ventricles (RV and LV) simultaneously (9).
The accuracy of using [11C]acetate to measure myocardial
oxygen uptake has been previously validated in animal
studies (10,11) and also in patients with idiopathic dilated
cardiomyopathy (DCM) (12). The use of [11C]acetate in
combination with non-invasive measures of ventricular
function to estimate myocardial efficiency in patients with
DCM has been successfully established (12–14).
The purpose of this study was to investigate the influence
of long-term exercise training on myocardial energetics and
efficiency in patients with idiopathic DCM and mild HF.
METHODS
Patient population. A total of 20 patients with idiopathic
DCM and HF were enrolled in the study. All patients were
clinically stable under active medical treatment (New York
Heart Association [NYHA] class 1.47  0.51) and did not
have evidence of decompensated HF at the time of the
study. All patients were receiving stable medical therapy,
including beta-blockade, for at least three months before the
start of the study (with a minor change in one patient two
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weeks before the start of the study: atenolol from 12.5 to 25
mg/day). Exclusion criteria included a history of ischemic
heart disease (as generally documented by angiography or
stress nuclear imaging), diabetes mellitus, primary valvular
disease, tobacco use, uncontrolled hypertension, and ortho-
pedic limitations. The patients were separated into two
groups based on living proximity to the exercise training
site. This process was based solely on logistic factors and
took place without the investigators’ knowledge of the
patient’s functional capacity, medical status, or physical
examination results. The training group (n 9) participated
in a five-month training program that included both endur-
ance and strength training components. The non-training
group (n  11) served as a control group and continued
medical therapy as advised by their physician.
The patient groups did not differ in terms of body size,
peak oxygen uptake (VO2), ejection fraction, and NYHA
functional class. Both patient groups also followed similar
medication regimens (Table 1).
No significant changes in medication took place during
the study. One patient from each group had atrial fibrilla-
tion. Four patients in the control group were withdrawn
from the study: one patient had a biventricular pacemaker
implanted; one was hospitalized for worsening HF, and thus
medical therapy was changed; and two patients withdrew
voluntarily. Thus, 16 patients completed the entire study:
nine in the training group and seven in the control group.
The study protocol was approved by the local Ethical
Committee and was carried out in accordance with institu-
tional guidelines. The purpose and potential risks of the
study were explained to all subjects, and all subjects gave
written, informed consent.
Study design. All study procedures were completed under
the same conditions and at the same time of day for both the
baseline and follow-up tests. All patients were instructed to
follow their normal medication regimen on the study days.
The PET study day consisted of an echocardiographic study
and two PET studies. Basal myocardial perfusion was
assessed using [15O]H2O, and hyperemic perfusion was
assessed after dipyridamole administration. Myocardial ox-
idative metabolism was assessed using [11C]acetate.
Cardiopulmonary exercise testing and training pro-
gram. All study subjects underwent a symptom-limited,
incremental cycle ergometer test with continuous respiratory
gas exchange analysis (Vmax; Sensormedics, Bilthoven, The
Netherlands), and peak VO2 was measured. The training
program consisted of an orientation period followed by
three supervised exercise sessions per week for five months.
All patients were continuously monitored by telemetry.
Initial exercise intensity was 50% of peak VO2 and progres-
sively increased during the five-month period to reach a goal
of 70% and a duration of 45 min. The resistance training
component, added four weeks after the start of the training
program, took place twice per week. It consisted of nine
different exercises for the trunk and upper and lower
extremities. All patients were asked to complete two home-
exercise sessions per week in which they adjusted their
exercise intensity according to a rating of perceived exertion
and heart rate (HR) monitors (Pacer NV, Polar Electro Oy,
Kempele, Finland).
Percent body fat was determined from skinfold measure-
ments (15). All study patients also completed the “RAND
36-Item Health Survey” to assess health-related quality of
life (16).
Echocardiographic evaluation. Measurements of LV
function was assessed using two-dimensionally guided
M-mode echocardiography (Acuson 128XP, Acuson Inc.,
Mountain View, California) to determine end-diastolic and
end-systolic wall thicknesses, LV dimensions, and volumes.
Left ventricular mass was calculated according to the Penn
convention (17). Meridional LV wall stress was calculated
according to Grossman et al. (18). Systemic vascular resis-
tance was estimated as mean arterial pressure divided by
cardiac output (19). External, or forward, LV work power
was calculated as: systolic blood pressure (BP)  stroke
volume  HR , and forward LV work power per gram of
tissue was calculated as: forward LV work power/LV mass.
Measurement of myocardial perfusion and oxidative me-
tabolism. The positron-emitting tracers—[15O]H2O and
[11C]acetate—were produced as previously described
(20,21). Subjects reported to the PET Centre in the fasted
Abbreviations and Acronyms
BP  blood pressure
DCM  dilated cardiomyopathy
HF  heart failure
HR  heart rate
kmono  [
11C]acetate clearance rate
LV  left ventricle or ventricular
NYHA  New York Heart Association
PET  positron emission tomography
ROI  region of interest
RV  right ventricle or ventricular
VO2  oxygen uptake
Table 1. Patient Characteristics
Training Group
(n  9)
Control Group
(n  7)
Gender (male/female) 7/2 7/0
Age (years) 55  8 55  8
BMI (kg/m2) 27.8  8.7 30.0  3.4
Peak oxygen uptake (ml/kg/per min) 19.4  4.1 20.6  4.2
Ejection fraction (%) 33.3  8.3 35.3  7.4
NYHA functional class 1.6  0.5 1.2  0.4
Medications
ACE inhibitors 78% (7/9) 86% (6/7)
Beta-blockers 78% (7/9) 100% (7/7)
Diuretics 33% (3/9) 14% (1/7)
Digoxin 33% (3/9) 29% (2/7)
Angiotensin II blocker 11% (1/9) 0
Data are presented as the mean value  SD or percentage (n/N) of subjects.
ACE  angiotensin-converting enzyme; BMI  body mass index; NYHA 
New York Heart Association.
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state. After the echocardiographic study, the subjects were
positioned supine in an eight-ring, 15-slice ECAT 931/08
tomograph (CTI, Knoxville, Tennessee). The [15O]H2O
studies were performed according to established protocols
(22). Thereafter, an intravenous bolus of [11C]acetate
(724  19 MBq) was administered simultaneously with the
start of a 29-min (10  10, 1  60, 5  100, 5  120, 2
 240 s) dynamic emission scan. Heart rate and BP were
monitored throughout all procedures. All PET data were
corrected for dead time, decay, and measured photon
attenuation. Images were processed using the iterative
reconstruction algorithm (23).
Calculation of myocardial perfusion, oxidative metabo-
lism, and efficiency. Regions of interest (ROI) were drawn
on an average of four transaxial mid-LV slices in each study.
An average of the lateral and anterior wall ROIs was used to
represent the LV. An additional ROI was drawn on the free
wall of the RV for RV [11C]acetate clearance rate (kmono)
determination in the [11C]acetate study. For the myocardial
perfusion analysis, ROIs were drawn on the rest images and
then copied to the images obtained after dipyridamole
administration. Regional myocardial perfusion was calcu-
lated using the single-compartment model (24). A LV
cavity ROI was drawn and used as the input function for
determination of the LV time–activity curve (25).
Myocardial perfusion reserve was defined as the ratio of
perfusion after dipyridamole infusion to rest perfusion.
Regional oxidative metabolism was derived by monoexpo-
nential fitting of kmono after visual determination of the
linear portion of the semi-logarithmic plot (26).
Myocardial efficiency (the relationship between forward
work and oxygen consumption) was estimated as: forward
LV work power per gram/LV kmono.
Biochemical analysis. Plasma glucose concentrations were
analyzed in duplicate by using the glucose oxidase method
with an Analox GM7 or GM9 glucose analyzer (Analox
Instruments Ltd., London, United Kingdom). Serum insu-
lin was measured using an automated time-resolved im-
munofluorometric assay (Autodelfia, Wallac, Turku, Fin-
land), and serum free fatty acid concentrations were
measured using an enzymatic colorimetric method (Wako
Chemicals Inc., Neuss, Germany). Plasma lactate concen-
trations were measured using a standard enzymatic method
(Roche Diagnostics, Basel, Switzerland). Lipid concentra-
tions were measured as previously described (22).
Statistical analysis. All data are expressed as the mean
value  SD. Intra-group comparisons (baseline vs. follow-
up) were made using the Wilcoxon signed-rank test. Inter-
group comparisons and relative changes in the training
group compared with the control group were made using
the Wilcoxon rank-sum test. All tests were two-sided, and
a p value 0.05 was considered statistically significant.
Correlation coefficients were calculated using the Spearman
rank correlation coefficient. All statistical analyses were
performed using the SAS statistical analysis system (SAS
Institute Inc., Cary, North Carolina).
RESULTS
Exercise training program. The duration of the interven-
tion period was similar in both the trained (179  6 days)
and non-trained control groups (176  8 days; p  0.37).
No adverse events took place during any of the training
Table 2. Hemodynamic, Echocardiographic, and Functional Data
Training Group Control Group
Baseline Follow-Up Change (%) Baseline Follow-Up Change (%)
Hemodynamic parameters
Heart rate (beats/min) 69  14 60  9 10.0 65  8 65  14 1.0
SBP (mm Hg) 117  20 120  15 3.2 133  19 128  12 3.2
DBP (mm Hg) 63  13* 70  9 14.3 78  13* 82  8 6.0
RPP (mm Hg/min) 7, 941  1, 411 7, 265  1, 476 7.7 8, 633  1, 718 8, 335  2, 291 3.9
Echocardiographic parameters
LV mass (g) 432  132 428  134 0.5 323  68 338  61 6.4
Wall stress (mm Hg) 779  414 603  319 16.4 733  435 614  203 8.3
LVEDD (mm) 74.1  9.3 72.4  10.9 2.4 67.9  6.3 67.6  6.2 0.5
LVESD (mm) 62.2  10.2 58.8  11.3† 5.7 56.4  7.2 55.1  6.4 2.1
SV (ml) 94  21 104  26† 10.8 83  17 87  16 6.0
SVR (dynes  s  cm5) 999  425 1, 091  323 22.2 1, 418  382 1, 410  230 3.6
EF (%) 33.3  8.3 38.6  8.5‡ 16.9 35.3  7.4 37.3  5.9 7.2
Functional capacity
Peak VO2 (ml/kg/per min) 19.4  4.1 24.6  5.2‡ 27.2 20.6  4.2 21.2  2.9 4.2
Peak VO2 (l/min) 1.7  0.5 2.1  0.7‡ 27.7 1.9  0.5 2.0  0.4 5.9
Peak work load (W) 139  40 161  42‡ 16.9 147  39 146  29 1.0
Exercise test time (min:s) 11:33  3:56 14:34  5:03‡ 27.8 12:13  2:36 12:25  1:31 4.4
NYHA functional class 1.6  0.5 1.2  0.5 18.5 1.2  0.4 1.1  0.4 4.8
*p  0.05 between groups at baseline; †p  0.05, ‡p  0.01 vs. baseline. Data are presented as the mean value  SD.
DBP  diastolic blood pressure; EF  ejection fraction; LV  left ventricle; LVEDD  left ventricular end-diastolic diameter; LVESD  left ventricular end-systolic
diameter; NYHA  New York Heart Association; RPP  rate–pressure product; SBP  systolic blood pressure; SV  stroke volume; SVR  systemic vascular resistance;
VO2  oxygen consumption.
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sessions. The average exercise intensity was 72  10% of
initial peak VO2, and the patients averaged 92  35 min per
week of home exercise. Attendance was 88  12% for the
21-week training program (64  4 sessions).
Functional capacity. Exercise training was associated with
a 27% improvement (p  0.01 vs. change in control group)
in peak VO2 (Table 2). Exercise training also improved the
peak work load and duration of the exercise test (p  0.05
for both vs. change in control group). No changes were
observed in the control group. The NYHA functional class
improved slightly but non-significantly in the training group
(p  0.13).
Hemodynamic and echocardiographic parameters. At
baseline, the hemodynamic parameters were similar be-
tween the groups, except for diastolic BP, which was slightly
lower in the training group (Table 2). Exercise training did
not elicit a change in systolic BP, rate–pressure product, or
systemic vascular resistance, but tended to decrease the
resting HR (p  0.06). Training increased the stroke
volume (p  0.05) and ejection fraction (p  0.01) and
reduced the LV end-systolic diameter (p  0.05). Training
also tended to reduce LV wall stress (p 0.10). No changes
were observed from baseline in any of the aforementioned
parameters in the control group.
Anthropometric and biochemical assessments. Exercise
training elicited a significant decrease (5%) in body fat
percentage and fasting levels of plasma lactate in the
training group (p  0.05 vs. change in control group). No
changes were noted in the other biochemical variables
assessed, and no changes were observed in the control group
(Table 3).
Health-related quality of life. Of the eight health con-
cepts for quality of life, the training group had improve-
ments from baseline in the areas of “general health,” “pain,”
(p  0.05 for both) and “vitality” (p  0.14). The only
change noted in the control group was in the area of “role
limitations caused by physical health problems,” where
subjective scores slightly decreased (p  0.06).
Myocardial perfusion. Exercise training elicited a reduc-
tion in basal myocardial perfusion (p  0.05 vs. baseline; p
 0.06 vs. change in control group), although no change
was noted in stimulated perfusion (Fig. 1A). Perfusion
reserve also remained unchanged after the training period.
No significant changes in basal or stimulated perfusion (Fig.
1B) or perfusion reserve were observed in the control group.
Myocardial oxidative metabolism, work, and efficiency.
Exercise training elicited significant reductions (10%) in
both RV and LV oxidative metabolism in the training group
(Fig. 2A). No significant changes occurred in either RV or
LV oxidative metabolism in the control group (Fig. 2B).
The LV work parameters did not change with exercise
training (Table 4). Myocardial forward work efficiency was
improved by 24% (p  0.05 vs. baseline; p  0.08 vs.
change in control group). In addition, the decrease in LV
oxidative metabolism was comparable to the change in
perfusion (10% and 12%, respectively). There were no
observable changes from baseline in the aforementioned
parameters in the non-trained group.
DISCUSSION
This study was designed to investigate the effects of exercise
training on myocardial energetics and efficiency in patients
with mild HF due to DCM. Exercise training elicited
significant improvements in functional parameters charac-
terized by increased exercise capacity and work load during
the exercise test. The patients who participated in the
training program also demonstrated significant changes in
LV functional parameters, including an increase in ejection
fraction and a decrease in end-systolic diameter. Most
notably, exercise training significantly reduced biventricular
oxidative metabolism and improved forward work efficiency,
as compared with non-trained patients.
LV oxidative metabolism and efficiency. The findings of
the present study demonstrate that LV oxygen demand is
decreased after training, as measured directly by the clear-
ance kinetics of [11C]acetate. This decrease occurred inde-
Table 3. Anthropometric and Biochemical Data
Training Group
(n  9)
Control Group
(n  7)
Baseline Follow-Up Change (%) Baseline Follow-Up Change (%)
Weight (kg) 86.5  27.8 87.7  29.4 1.2 93.5  11.0 94.7  10.8 1.3
BMI (kg/m2) 27.8  8.7 28.2  9.2 1.2 30.0  3.4 30.3  3.5 1.3
Body fat (%) 22.4  4.7 21.3  5.2* 5.3 24.4  3.8 24.4  3.9 0.1
fS-total cholesterol (mmol/l) 5.7  0.8 5.8  1.0 1.8 5.1  0.6 5.1  0.7 0.3
fS-HDL cholesterol (mmol/l) 1.4  0.5 1.5  0.5 3.0 1.1  0.1 1.0  0.2 5.5
fS-LDL cholesterol (mmol/l) 3.5  1.0 3.7  0.9 9.5 3.5  0.3 3.4  0.6 2.3
fS-trigylcerides (mmol/l) 1.8  1.2 1.4  0.6 9.3 1.3  1.0 1.4  0.9 23.7
fP-glucose (mmol/l) 5.8  1.2 5.9  1.0 2.6 5.8  0.4 5.5  0.5 5.1
fP-lactate (mmol/l) 1.2  0.4 1.0  0.3* 16.0 1.3  0.5 1.3  0.3 11.2
fS-FFA (mmol/l) 0.66  0.32 0.56  0.20 8.3 0.57  0.33 0.62  0.39 23.3
fS-insulin (mU/l) 8.1  4.4 6.5  2.1 10.4 11.1  6.4 12.6  9.7 8.0
*p  0.05 vs. baseline. Data are presented as the mean value  SD.
BMI  body mass index; HDL  high-density lipoprotein; FFA  free fatty acids; LDL  low-density lipoprotein; fP  fasting plasma; fS  fasting serum.
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pendent of a change in useful forward myocardial work,
resulting in enhanced LV work efficiency; in other words,
the oxygen cost of forward work was decreased.
Forward work efficiency accounts for 12% to 20% of
total LV oxygen consumption in the healthy heart (27).
Most of the remaining available energy is converted to heat,
and only a small portion is used for basal metabolism and
other cellular processes. From the clinical point of view,
forward work efficiency is important because the heart works
to satisfy the body’s needs (blood circulation), and the
amount of energy used to achieve this is what is relevant.
LV function. The findings of improved LV function after
exercise training in this study are in agreement with Ham-
brecht et al. (8) and Webb-Peploe et al. (28). However, in
some previous studies, significant changes in ejection frac-
tion were not detected after exercise training in patients
with HF (3,29). The improvement in ejection fraction in
the present study correlated nicely with the observed im-
provement in exercise capacity of the trained patients (r 
0.72, p  0.03).
Mechanisms. One potential explanation for the downward
shift in myocardial oxidative metabolism could be due to a
shift in substrate preference to a more energy-efficient
substrate. A switch in substrate utilization from fatty acids
to glucose oxidation would be more energy efficient (30).
However, the findings regarding substrate metabolism in
the failing heart are controversial. Recent studies have
shown an increase in the whole-body free fatty acid turnover
rate and oxidation (31) and myocardial free fatty acid uptake
(32) in HF patients. In contrast, some studies have found
Figure 1. Basal myocardial perfusion and stimulated perfusion in the training group (A) and non-trained control group (B). The open bars represent the
baseline study, and the solid bars represent the follow-up study. *p  0.05 vs. baseline.
464 Stolen et al. JACC Vol. 41, No. 3, 2003
Exercise Improves Myocardial Oxidative Metabolism February 5, 2003:460–7
that in the failing heart, substrate metabolism may revert to
a more fetal condition, with enhanced glucose uptake and
reduced fatty acid oxidation (33–35).
Two previous intervention studies investigating the ef-
fects of beta-blocker therapy in patients with HF demon-
strated that beta-blocker therapy decreased LV oxidative
metabolism by 24% (36) and also decreased myocardial free
fatty acid uptake by 57% (37). It is important to note that
the majority of the patients in the present study were already
receiving stable beta-blocker therapy and continued the
same medication regimen throughout the intervention pe-
riod. Therefore, the myocardial energetic and metabolic
shift demonstrated in the studies by Beanlands et al. (36)
and Wallhaus et al. (37) most likely had already taken place.
Thus, in the present study, the energy-sparing effect ob-
tained from the training program is an additional benefit.
Myocardial efficiency can also be enhanced by decreasing
afterload (13). In the present study, afterload, as assessed by
either cardiac work load, rate–pressure product, or systemic
vascular resistance, did not change with exercise training. A
decrease in sympathetic drive, which has been observed with
exercise training (10) and is also suggested by the slight
Figure 2. Biventricular oxidative metabolism during the baseline and follow-up studies in the training group (A) and control group (B). *p  0.05 vs.
baseline. †p  0.05 vs. change in control group.
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decrease in resting HR in this study, could enhance myo-
cardial efficiency as well, because increased adrenergic stim-
ulation is an independent determinant of reduced efficiency
in the failing heart (38).
RV parameters. The unique nature of this study is that it
also provides data from the RV. Heart failure leads to
significant changes in RV function and metabolism. Func-
tion of the RV has been associated with exercise capacity
(39,40) and prognosis (39). We have previously shown that
HF is associated with increased RV oxidative metabolism
(41); however, no data are available on the effects of
different treatments on RV parameters. In the present study,
exercise training elicited a significant and similar degree of
decrease (10%) in oxidative metabolism in both the RV and
LV. It is likely that this change is linked to the improvement
in LV function, resulting in reduced loading of the right
side of the heart. However, we cannot exclude other
potential mechanisms such as improvement in work effi-
ciency or substrate metabolism. Because the measurement
of work power in the RV requires invasive procedures, we
could not include those measurements in the present pro-
tocol.
Study limitations. Owing to the limited number of pa-
tients available for this demanding study, a blinded random-
ization procedure could not take place. However, patients
were separated into their respective group based solely on
their proximity to the training site. Living in close proximity
to the training site was mandatory in order to perform this
intensive supervised training program. This process was
unbiased, as it took place without the investigator’s knowl-
edge of the patient’s present physical health status or
functional capacity.
During all testing procedures, the patients were in-
structed to continue their normal medication regimen, and
this may have influenced myocardial metabolism and ener-
getics. Therefore, the extension of these results to untreated
or unstable patients with HF may be limited. It is also
important to note that the etiology of HF of the patients in
this study was idiopathic DCM; thus, the results may not
extrapolate to patients with ischemic cardiomyopathy.
Myocardial efficiency is dependent on the loading condi-
tions of the heart. As stated previously, afterload was
unchanged, but a direct measurement of preload was not
possible in the present non-invasive study. However, end-
diastolic LV diameter, a surrogate for preload, was not
changed in this study. In addition, because all patients were
clinically stable and did not have significant medication
changes during the study or evidence of decompensation
before the start of the study, it is unlikely that significant
changes in preload occurred.
Conclusions. Exercise training in patients with idiopathic
DCM and mild HF leads to a significant reduction in
biventricular oxidative metabolism and a favorable improve-
ment in forward work efficiency. This energy-sparing effect
of exercise training in patients with DCM and mild HF
underscores the importance of the inclusion of an exercise
training as concomitant therapy for the treatment and
prevention of chronic HF.
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